4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
CytoMed Therapeutics Limited (GDTC) operates in the Biotechnology industry and is headquartered in Singapore, Singapore with about 42 employees. Its market capitalization is roughly $11 million. In the fiscal year ended 2025-12-31, GDTC reported SGD 0M in revenue and (SGD 4M) in net income.
CytoMed Therapeutics Limited, a clinical stage biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore.
Interactive charts & full statements → Open the GDTC valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | SGD 0M | SGD 0M | SGD 0M | SGD 0M | — |
| Gross Profit | SGD 0M | SGD 0M | SGD 0M | SGD 0M | — |
| Operating Income (EBIT) | (SGD 4M) | (SGD 3M) | (SGD 4M) | (SGD 2M) | — |
| Net Income | (SGD 4M) | (SGD 2M) | (SGD 4M) | (SGD 3M) | — |
SGD; SGDM / SGDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | SGD 0M | SGD 0M | SGD 0M | SGD 0M | — |
SGD; SGDM / SGDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | SGD 8M | SGD 10M | SGD 12M | SGD 5M | — |
| Total Liabilities | SGD 1M | SGD 1M | SGD 1M | SGD 5M | — |
SGD; SGDM / SGDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GDTC viewer.
About TickerBase · Data methodology & sources · Privacy · Terms